The Patent Finder

Aegerion Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Aegerion Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Aegerion Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,087,228A Chimeric Leptin Polypeptide and Method of Using the Same
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,535,659Engineered Polypeptides Having Enhanced Duration of Action
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,879,063Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,213,419Compound Impurities and Methods of Detecting Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,775,386Methods of Detecting Anti-Leptin Neutralizing Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,709,166Methods of Detecting Anti-Leptin Neutralizing Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited